Mitsubishi Chemical Group Corporation

FY2025 sales revenue was JPY 3,704 billion, down JPY 343.6 billion year on year; core operating income was JPY 225 billion, down JPY 3.8 billion; operating income was JPY 3.1 billion; income before taxes was JPY 0.7 billion; and net income attributable to owners of the parent was JPY 11.8 billion, down JPY 33.2 billion year on year. Special items were negative JPY 194.9 billion, and the Soarnol U.K. impairment alone was about JPY 30.3 billion. For FY2026, management guided to sales revenue of JPY 3.8 trillion, core operating income of JPY 305 billion, operating income of JPY 300 billion, income before taxes of JPY 270 billion, and net income attributable to owners of the parent of JPY 227 billion. The FY2026 dividend forecast is JPY 32 per share, with JPY 16 interim and JPY 16 year-end.

CEO Manabu Chikumoto framed FY2025 as an exceptionally difficult year because the company chose to take large one-time charges to finish structural reforms quickly and cleanly. He apologized to shareholders for the shortfall versus prior guidance and said management has tightened oversight of investment projects after the Soarnol U.K. impairment, noting no similar risks have emerged elsewhere so far. His tone was serious but forward-looking, emphasizing that Specialty Materials, semiconductor-related businesses, carbon fiber composites for robotaxis, aerospace, and European film investments should drive a meaningful profit step-up in FY2026.

CFO Minoru Kida detailed FY2025 sales revenue of JPY 3,704 billion, core operating income of JPY 225 billion, and special items of negative JPY 194.9 billion, which pushed operating income to JPY 3.1 billion and net income attributable to owners of the parent to JPY 11.8 billion. He highlighted that the Chemicals segment posted core operating income of JPY 24.3 billion, with Specialty Materials up JPY 8.4 billion and industrial gases up JPY 14.6 billion, but MMA and Soarnol-related impairments weighed heavily. On cash flow, he cited operating cash inflow of JPY 436.3 billion, cash flow positive JPY 560.8 billion, net interest-bearing debt down to JPY 387.5 billion, and the net D/E ratio improving to 0.83 from 1.06. For FY2026, he guided to core operating income of JPY 305 billion, net income attributable to owners of the parent of JPY 227 billion, and a JPY 32 per share annual dividend.

Analysts pressed management on the Middle East impact, especially how much of the JPY 18 billion downside was tied to raw materials, inventory revaluation, and supply disruptions. Management said the bigger issue is volume and supply-chain disruption rather than direct cost inflation, with MMA and related products accounting for a large share of the exposure; they also said cost increases could generally be passed through if needed. Questions on Specialty Materials focused on the large FY2026 profit increase and robotaxi carbon fiber shipments, and management confirmed shipments are expected to ramp to roughly triple or 4x, while also citing the disappearance of Soarnol impairment charges and contributions from German film investment and semiconductor-related demand. On petrochemicals and naphtha, management said April looked favorable on inventory receipts but they were not ready to break out detailed quarterly impacts.